| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/11/2006 | EP1127064B1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 01/11/2006 | EP1119630B1 Nucleic acid constructs for genetic immunisation |
| 01/11/2006 | EP1104306B1 Compositions of cpg and saponin adjuvants and methods of use thereof |
| 01/11/2006 | EP1073749B1 Enhancing immune responses to genetic immunization by using a chemokine |
| 01/11/2006 | EP1063294B1 Dnas or genes participating in parkinson's disease |
| 01/11/2006 | EP1029056B1 Plant-optimized genes encoding pesticidal toxins |
| 01/11/2006 | EP1019545B1 Methods and reagents for preserving rna in cell and tissue samples |
| 01/11/2006 | EP1012230B1 Renibacterium salmoninarum vaccine |
| 01/11/2006 | EP1009768B1 Human persephin |
| 01/11/2006 | EP1004671B1 Process for producing l-glutamic acid by fermentation method |
| 01/11/2006 | EP1002060B1 Alkaline xyloglucanase |
| 01/11/2006 | EP0989805B1 Nucleic acid sequences for atp-binding cassette transporter |
| 01/11/2006 | EP0868519B1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 01/11/2006 | EP0830450B1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof |
| 01/11/2006 | EP0824599B1 Universal targets for species identification |
| 01/11/2006 | EP0797672B1 Use of a sec-dependent secretion system for secreting proteins that are usually secreted by a sec-independent secretion system |
| 01/11/2006 | EP0787142B1 Neurturin and related growth factors |
| 01/11/2006 | EP0776972B1 GENE CODING FOR IgG-Fc-BINDING PROTEIN |
| 01/11/2006 | EP0771352B1 Nontypable haemophilus influenzae lkp tip adhesin protein and nucleic acid |
| 01/11/2006 | EP0766569B1 Aav capsid vehicles for molecular transfer |
| 01/11/2006 | EP0764210B1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 01/11/2006 | EP0745130B1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay |
| 01/11/2006 | EP0731636B1 Cdn apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720453A Method of immobilizing polynucleotide on solid support, solid immobilization support thus obtained, method of detecting target polynucleotide from the solid support and solution for immobilizing polyn |
| 01/11/2006 | CN1720442A CIZI replication protein |
| 01/11/2006 | CN1720336A Use of A33 antigens and JAM-IT |
| 01/11/2006 | CN1720330A Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) and herbicide-tolerant plants containing it |
| 01/11/2006 | CN1720329A New expression system from rhodococcus |
| 01/11/2006 | CN1720328A L-rhamnose-inducible expression systems |
| 01/11/2006 | CN1720327A Compositions, organisms and methodologies employing a novel human kinase |
| 01/11/2006 | CN1720326A Method of strengthening foreign epitope presentation by MHC class I by inhibiting TAP activity |
| 01/11/2006 | CN1720325A Process for producing dipeptides |
| 01/11/2006 | CN1720263A Trimeric binding proteins for trimeric cytokines |
| 01/11/2006 | CN1720261A 疫苗 Vaccine |
| 01/11/2006 | CN1720257A Methods of down regulating target gene expression in vivo by introduction of interfering RNA |
| 01/11/2006 | CN1720066A Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 01/11/2006 | CN1719973A Compositions and methods for cancer diagnosis and therapy |
| 01/11/2006 | CN1719971A Transgenic high tryptophan plants |
| 01/11/2006 | CN1718734A Peritoneum transgene method |
| 01/11/2006 | CN1718733A Surface glucoprotein gp160 of recombination expression human acquired immunity defact virus 1 |
| 01/11/2006 | CN1718732A Electric conversion method of making shuttle plasmid guide into yellow brevibacterium |
| 01/11/2006 | CN1718731A HCV transgene mouse model and its construction method and application |
| 01/11/2006 | CN1718730A Anti tumour fusion protein and its coding gene and application |
| 01/11/2006 | CN1718729A Function and use of human immune cell inhibition acceptor KLRL1 |
| 01/11/2006 | CN1718728A Extraction method of Pu goa feaces DNA |
| 01/11/2006 | CN1718726A Reconstitution bacteria strain for expressing human lactoferro protein and its culturing method |
| 01/11/2006 | CN1718588A Monoclone antibody for anti HLA-G and hybrid tumour cell secreting same, cancer dignosis method, diagnosis reagent box and its application |
| 01/11/2006 | CN1718585A Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease |
| 01/11/2006 | CN1718276A Dialkyl glutamic surgar ester surfactant, prepn. method and use thereof |
| 01/11/2006 | CN1718242A Recombination vaccine of dog-2 type adenovirus for lyssic virus gluco-/nucleo-structured protein |
| 01/11/2006 | CN1718241A Buckwheat trypsase inhibitor, expression and application thereof |
| 01/11/2006 | CN1236066C Process for producing L-amino acid via fermentation method |
| 01/11/2006 | CN1236064C Expression regulatory sequence |
| 01/11/2006 | CN1236063C Method for the production of 1,3-propanediol by recombinant organisms |
| 01/11/2006 | CN1236062C cDNA related with plant top development and novel method for weakening plant apical dominance and increasing branch number |
| 01/11/2006 | CN1236061C Promotor for controlling plant root system development and use thereof |
| 01/11/2006 | CN1236060C Gene for controlling plant root system development and its coding products and use |
| 01/11/2006 | CN1236059C Rockfish insulin-like growth factor II gene, carrier and recombinant strain containing the gene and their application |
| 01/11/2006 | CN1236057C Recombinant gland related virus expressing human kallikrein, its preparation method and application |
| 01/11/2006 | CN1235911C Multiple cytokine-antibody complexes |
| 01/11/2006 | CN1235909C Recombination human interferon alpha 8 polypeptide coding cDNA sequence, preparation method and application |
| 01/10/2006 | US6984774 activating homologous recombination in plants using transposases; controlling expression of genes useful for disease or drought resistance, fertility, fruit ripening, oil or pigment biosynthesis, seed formation and starch metabolism |
| 01/10/2006 | US6984773 Transgenic mice expressing a human SXR receptor polypeptide |
| 01/10/2006 | US6984772 Transgenic non-human mammals producing fibrinogen in their milk |
| 01/10/2006 | US6984771 Mice heterozygous for WFS1 gene as mouse models for depression |
| 01/10/2006 | US6984729 Oligonucleotides specific for hepatitis B virus |
| 01/10/2006 | US6984728 Recombinant infectious laryngotracheitis virus for use as tool in prevention of viral infections |
| 01/10/2006 | US6984727 in-vivo signal transduction; growth control |
| 01/10/2006 | US6984726 Recombinant major allergen of the pollen of Artemisia vulgaris (mugwort) |
| 01/10/2006 | US6984720 cytotoxic t lymphocytes; immunology |
| 01/10/2006 | US6984630 Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection |
| 01/10/2006 | US6984625 Methods and compositions for modulating autoimmunity |
| 01/10/2006 | US6984623 Tendon-inducing compositions |
| 01/10/2006 | US6984523 Carotenoid ketolase gene |
| 01/10/2006 | US6984522 Isolation and use of solid tumor stem cells |
| 01/10/2006 | US6984520 thyrotropin receptor (TSH-R) or TSH autoantibodies; kits; luciferases; cyclic cAMP promoters |
| 01/10/2006 | US6984518 DNA construct comprising an FGF1B promoter region operably linked to an SV40 large T antigen encoding sequence |
| 01/10/2006 | US6984517 Pair of Adeno Associated Virus 5 (AAV5) inverted terminal repeats and promoter; not rescued by other serotypes; uneffected by heparin, not restricted to same cell types as AAV2; transduction in patient with neutralizing antibodies; gene therapy |
| 01/10/2006 | US6984515 Macrolide analogs |
| 01/10/2006 | US6984514 Genetically engineered microorgansim for the generation of preferential amino acid for use in medicine and food |
| 01/10/2006 | US6984513 Anaerobe targeted enzyme-mediated prodrug therapy |
| 01/10/2006 | US6984512 Bacterial strains, methods of preparing the same and use thereof in fermentation processes for L-lysine production |
| 01/10/2006 | US6984511 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/10/2006 | US6984509 Steroid dehydrogenase 34 and the polynucleotide encoding same |
| 01/10/2006 | US6984504 Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons |
| 01/10/2006 | US6984503 therapeutic uses of rbosCD14 both as an inhibitor of activation which occurs in an acute inflammatory response and as a sensitizer of bovine mammary ductal epithelial cells resulting in leukocyte recruitment and initiation of immune response |
| 01/10/2006 | US6984502 Methods and compositions of human 69087 nucleic acids and uses thereof |
| 01/10/2006 | US6984501 used in test systems which are suitable for identifying substances modulating, opening or closing the Kv2,1/Kv6.2 channels and which can be used as therapeutic agents |
| 01/10/2006 | US6984496 Vitro assay for testing gabapentinoid activity |
| 01/10/2006 | US6984493 Method for examining the involvement of opioid peptides in prurtis |
| 01/10/2006 | US6984490 Identification of genes |
| 01/10/2006 | US6984489 system for screening potential new drugs for susceptibility to metabolic action in patients; cytochrome P450 (P450) termed CYP3A4 is an important human gene that codes for an enzyme expressed in the liver |
| 01/10/2006 | US6984488 Determination and control of bimolecular interactions |
| 01/10/2006 | US6984487 Cystic fibrosis gene |
| 01/10/2006 | US6984485 Coating a solid support via chemical plasma polymerization, and forming pendant functional group(s) for attaching a protein, nucleic acid or cell; polyacrylic acid with pendant acid groups converted to acyl fluorides for example |
| 01/10/2006 | US6984387 Immunogenic peptides of foot-and-mouth disease viruses |
| 01/10/2006 | US6984385 Immunological combination compositions and methods |
| 01/10/2006 | US6984384 A biodrug mixture contains a preheated fusion protein,comprising heat shock protein, glucose-regulated protein and immuogens; antigrowth agents; cancer, tuberculosis infection |
| 01/10/2006 | US6984382 Bifunctional protein, preparation and use |